X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14) 14
rheumatoid arthritis (14) 14
humans (12) 12
abridged index medicus (10) 10
clinical trials (9) 9
drug therapy (9) 9
rheumatology (9) 9
antirheumatic agents - therapeutic use (8) 8
arthritis (8) 8
arthritis, rheumatoid - drug therapy (8) 8
female (8) 8
internal medicine (8) 8
male (8) 8
medicine, general & internal (8) 8
middle aged (8) 8
double-blind method (7) 7
methotrexate (6) 6
modifying antirheumatic drugs (6) 6
monoclonal antibodies (6) 6
adult (5) 5
antibodies, monoclonal - adverse effects (5) 5
antibodies, monoclonal - therapeutic use (5) 5
double-blind (5) 5
methotrexate - therapeutic use (5) 5
patients (5) 5
severity of illness index (5) 5
treatment outcome (5) 5
aged (4) 4
antirheumatic agents - adverse effects (4) 4
arthritis, rheumatoid - physiopathology (4) 4
dosage and administration (4) 4
drug administration schedule (4) 4
drug dosages (4) 4
drug therapy, combination (4) 4
proteins (4) 4
rheumatoid factor (4) 4
studies (4) 4
american-college (3) 3
antibodies, monoclonal, humanized (3) 3
antirheumatic agents - administration & dosage (3) 3
c-reactive protein (3) 3
care and treatment (3) 3
disease (3) 3
etanercept (3) 3
inflammatory diseases (3) 3
joint diseases (3) 3
medical research (3) 3
monoclonal-antibody (3) 3
remission (3) 3
research (3) 3
rheumatism (3) 3
safety (3) 3
tumor necrosis factor-tnf (3) 3
activity score (2) 2
acute-phase reactants (2) 2
adalimumab (2) 2
adalimumab - administration & dosage (2) 2
adalimumab - therapeutic use (2) 2
analysis (2) 2
animals (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal, humanized - adverse effects (2) 2
antirheumatic agents (2) 2
arthritis, rheumatoid - diagnostic imaging (2) 2
arthritis, rheumatoid - pathology (2) 2
austria (2) 2
autoimmune diseases (2) 2
cells (2) 2
clinical outcomes (2) 2
clinical-trials (2) 2
combination (2) 2
data processing (2) 2
diseases (2) 2
dose-response relationship, drug (2) 2
epidemiology (2) 2
eular recommendations (2) 2
evaluation (2) 2
health aspects (2) 2
history (2) 2
immunoglobulin g - therapeutic use (2) 2
immunology (2) 2
infliximab (2) 2
janus kinase (2) 2
lupus (2) 2
medicine, experimental (2) 2
methotrexate - administration & dosage (2) 2
methotrexate - adverse effects (2) 2
mice (2) 2
necrosis-factor-alpha (2) 2
pain (2) 2
pharmaceutical industry (2) 2
placebo-controlled trial (2) 2
radiography (2) 2
randomized controlled-trial (2) 2
receiving concomitant methotrexate (2) 2
receptors, tumor necrosis factor - therapeutic use (2) 2
recommendations (2) 2
rheumatic diseases (2) 2
rheumatoid-arthritis (2) 2
rituximab (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 383, Issue 9914, pp. 321 - 332
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9870, pp. 918 - 929
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 390, Issue 10093, pp. 457 - 468
Summary Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MODIFYING ANTIRHEUMATIC DRUGS | NECROSIS-FACTOR | PLACEBO | JANUS KINASE INHIBITOR | INADEQUATE RESPONSE | LONG-TERM SAFETY | PLUS METHOTREXATE | AMERICAN-COLLEGE | OPEN-LABEL | COMBINATION | Antirheumatic Agents - administration & dosage | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Adalimumab - adverse effects | Arthritis, Rheumatoid - drug therapy | Pyrroles - administration & dosage | Antirheumatic Agents - adverse effects | Pyrroles - adverse effects | Adult | Female | Drug Therapy, Combination | Pyrroles - therapeutic use | Antirheumatic Agents - therapeutic use | Severity of Illness Index | Piperidines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Pyrimidines - administration & dosage | Treatment Outcome | Methotrexate - adverse effects | Adalimumab - therapeutic use | Adalimumab - administration & dosage | Piperidines - therapeutic use | Pyrimidines - therapeutic use | Piperidines - adverse effects | Pyrimidines - adverse effects | Methotrexate - administration & dosage | Rheumatoid factor | Care and treatment | Analysis | Clinical trials | Arthritis | Pharmaceutical industry | Methotrexate | Rheumatology | Patients | Studies | Rheumatoid arthritis | Monoclonal antibodies | Rheumatism | TNF inhibitors | Janus kinase | Tumor necrosis factor-TNF | Safety | Drug therapy | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article